Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment.

ABSTRACT:

Objective

Create a timeline of diagnosis and treatment for IPF in the US.

Design, setting, and participants

A retrospective analysis was performed in collaboration with the OptumLabs Data Warehouse using an administrative claims database of Medicare Fee for Service beneficiaries. Adults 50 and over with IPF were included (2014 to 2019).

Exposure

To focus on IPF, the following diagnoses were excluded: post-inflammatory fibrosis, hypersensitivity pneumonitis, rheumatoid arthritis, sarcoidosis, scleroderma, and connective tissue disease.

Main outcomes and measures

Data were collected from periods prior, during, and following initial clinical diagnosis of IPF. This included prior respiratory diagnoses, number of respiratory-related hospitalizations, anti-fibrotic a

SUBMITTER: Herberts MB 

PROVIDER: S-EPMC10398946 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature